Ipilimumab (anti-CTLA-4)

Synonyms: MDX-010, BMS-734016

Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD.

Ipilimumab (anti-CTLA-4) Chemical Structure

Click to purchase the isotype control of Ipilimumab (anti-CTLA-4)

Selleck's Ipilimumab (anti-CTLA-4) has been cited by 14 Publications

1 Customer Review

Purity & Quality Control

Batch: Purity: 99.83% Protein concentration: 5mg/ml Endotoxin Level: ≤1 EU/mg
99.83

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD.
Features Human IgG1
Targets
CTLA-4 [1]
(Cell-free assay)
In Vitro
In vitro

Pembrolizumab plus ipilimumab and nivolumab plus ipilimumab with chemotherapy have been approved by FDA for the first-line treatment of NSCLC patients.[1]

Cell Research:

For the intracellular cytokine analysis of TILs, cells from dissociated tumors in the density range of 1×105 to 1×106 cells were cultured in a 96-well U-bottom plate containing 10 µg/mL of pembrolizumab, 10 µg/mL of ipilimumab, soluble 50 ng/mL of anti-CD3, and 50 ng/mL of anti-CD28 for 24 h at 37°C, followed by the addition of brefeldin A and monensin. To measure interferon (IFN)-γ and tumor necrosis factor (TNF) secretion levels by CD8+ TILs according to PD-1 expression on anti-CD3 and anti-CD28 stimulation, the pre-incubation step without brefeldin A and monensin for 24 h was omitted. After 12 h, the cells were harvested and stained. Intracellular cytokines were stained after surface staining, fixation, and permeabilization with Foxp3 fixation/permeabilization solution.

In Vivo
In vivo

64Cu-labeled ipilimumab may be used to noninvasively monitor CTLA-4-expressing tissues in vivo.[2]

Animal Research

AnimalModels:Female athymic nude mice of human lung adenocarcinoma xenograft model
Formulation:buffer-exchanged to PBS, and conjugated with DOTA for radiolabeling with 64Cu (t1/2 = 12.7 h)
Dosages:~1 mg/mL
Administration:i.v.[2]

 

Product Details

CAS No. 477202-00-9
Isotype Human IgG1
Source CHO cells
Formulation PBS buffer, pH 7.2
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Frequently Asked Questions

Question 1:
How to store the antibody?

Answer:
Store the undiluted solution at 4 °C in the dark. Freezing antibodies can result in a loss of activity caused by the freezing/thawing process. Diluting antibodies to working concentrations and storing at 4°C for more than a day should be avoided. Additionally, make sure to keep the antibody sterile. Under these storage conditions, your antibodies should remain active for up to one year and oftentimes longer.

Tags: buy Ipilimumab (anti-CTLA-4) | Ipilimumab (anti-CTLA-4) supplier | purchase Ipilimumab (anti-CTLA-4) | Ipilimumab (anti-CTLA-4) cost | Ipilimumab (anti-CTLA-4) manufacturer | order Ipilimumab (anti-CTLA-4) | Ipilimumab (anti-CTLA-4) distributor